EVAR术后II型内漏:瘤囊行为-解剖驱动管理(SADM)框架
该综述总结EVAR术后II型内漏(T2EL)的诊断、监测与管理证据,T2EL发生率约10-30%,仅少数出现临床相关瘤囊增大。作者提出SADM框架,整合指南推荐与解剖因素,将治疗指征与操作策略分离,以瘤囊行为和解剖可行性指导决策。
要点
- T2EL见于约10-30%的EVAR术后患者,仅少数出现临床相关瘤囊增大。
- 监测策略主要由瘤囊动态变化驱动,而非仅依据T2EL存在。
- 持续内漏伴瘤囊增大应考虑干预,血管内栓塞仍是主要治疗方式。
核心结论
- T2EL管理应以瘤囊行为和解剖可行性为核心决策依据,SADM框架将治疗指征与操作策略分离。
- 持续内漏伴瘤囊增大者应考虑干预,血管内栓塞为主要治疗方式。
研究设计与样本
- 综述,总结T2EL诊断、监测与管理的当前证据,并提出SADM框架。
主要发现
- T2EL发生于约10-30%的EVAR术后患者,但仅少数出现临床相关瘤囊增大。
- 监测策略主要由瘤囊动态变化驱动,而非仅依据T2EL存在。
- 持续内漏伴瘤囊增大时应考虑干预。
- 血管内栓塞仍是主要治疗方式,但缺乏高质量对照数据,无单一技术显示明确优势。
- 近期随机证据未显示EVAR术中常规预防性栓塞肠系膜下动脉有明确获益。
关键数值与推荐
- T2EL发生率约10-30%(EVAR术后患者)。
- 干预指征:持续内漏伴瘤囊增大。
- 近期随机证据未显示常规预防性肠系膜下动脉栓塞在EVAR术中有明确获益。
临床怎么用
- 以瘤囊行为为监测核心,对持续内漏伴瘤囊增大者考虑干预。
- 血管内栓塞作为主要治疗方式,但需认识到缺乏高质量比较数据支持某一技术优势。
- SADM框架可将治疗指征与操作策略分离,结合解剖可行性进行决策。
局限性
- 缺乏高质量对照数据比较不同栓塞技术。
- 近期随机证据未显示常规预防性肠系膜下动脉栓塞有明确获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type II endoleak (T2EL) is the most common complication following endovascular abdominal aortic aneurysm repair (EVAR), although its clinical significance remains debated. While often benign, a subset of cases is associated with aneurysm sac enlargement and may require intervention. This review summarizes current evidence on the diagnosis, surveillance, and management of T2EL, with emphasis on decision-making guided by aneurysm sac behavior. Beyond summarizing available evidence, this review introduces and operationalizes the Sac Behavior-Anatomy-Driven Management (SADM) framework that integrates heterogeneous guideline recommendations and anatomical considerations into a unified, clinically applicable decision support strategy for T2EL management. T2EL occurs in approximately 10-30% of patients after EVAR, but only a minority demonstrate clinically relevant sac enlargement. Surveillance strategies are primarily driven by sac dynamics rather than the presence of T2EL alone. Intervention should be considered in cases of persistent endoleak with sac enlargement. Endovascular embolization remains the main treatment approach, although no single technique has demonstrated clear superiority in the absence of high-quality comparative data, and recent randomized evidence has not demonstrated a clear benefit for routine prophylactic inferior mesenteric artery embolization during EVAR. The proposed SADM framework provides a practical, clinically applicable approach to T2EL management by separating treatment indication from procedural strategy and aligning decision-making with aneurysm sac behavior and anatomical feasibility.
引用
- Błaszyk M, Fryska Z, Waliszewski J, et al. Type II Endoleak after EVAR: The Sac Behavior-Anatomy-Driven Management (SADM) Framework. Ann Vasc Surg. 2026. PMID: 42349644. doi:10.1016/j.avsg.2026.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。